Comparative Effects of Aerobic Exercises, Resistance Training and Combined Training on Heart Failure Patients

NCT ID: NCT04937231

Last Updated: 2021-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-15

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the effectiveness of aerobic training and resistance training and combined training on heart failure patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aerobic exercises

Treadmill and Cycle ergometer

Group Type EXPERIMENTAL

Aerobic exercises

Intervention Type OTHER

For Week 1 and 2 : Treadmill 3-5days/weeks

Intensity:

50-70 vo2 peak Or HRR 60-80% Duration of 10-20 minutes For Week 3 and 4; Cycle ergometer 3-5days/weeks

Intensity:

50-70 vo2 peak Or HRR 60-80% Duration of 30-40 minutes

Resistance exercises

unilateral leg press, Bilateral leg press, unilateral arm curls

Group Type EXPERIMENTAL

Resistance exercises

Intervention Type OTHER

For Week 1 and 2; 2 x 10 rep (unilateral leg press) 4x 12 reps (Bilateral leg press

1 x 8 rep ( unilateral arm curls For Week 3 and 4; 1 x 10 reps Shoulder press

1 x15 rep Bilateral knee extension

1 x 10 reps Bilateral arm curls

Combined training

Treadmill and Cycle ergometer along with resistive Training

Group Type EXPERIMENTAL

Combined training

Intervention Type OTHER

For Week 1 and 2; Aerobic exercise on Treadmill along with dumbbell to perform upper limb exercises (biceps curls, side curls extensions, upright row, back fly) and used Thera band to perform lower limb exercises for 10-20 minutes For Week 3 and 4; Aerobic exercise on Treadmill along with dumbbell and Thera band to perform upper limb and lower limb exercises for 30-40 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aerobic exercises

For Week 1 and 2 : Treadmill 3-5days/weeks

Intensity:

50-70 vo2 peak Or HRR 60-80% Duration of 10-20 minutes For Week 3 and 4; Cycle ergometer 3-5days/weeks

Intensity:

50-70 vo2 peak Or HRR 60-80% Duration of 30-40 minutes

Intervention Type OTHER

Resistance exercises

For Week 1 and 2; 2 x 10 rep (unilateral leg press) 4x 12 reps (Bilateral leg press

1 x 8 rep ( unilateral arm curls For Week 3 and 4; 1 x 10 reps Shoulder press

1 x15 rep Bilateral knee extension

1 x 10 reps Bilateral arm curls

Intervention Type OTHER

Combined training

For Week 1 and 2; Aerobic exercise on Treadmill along with dumbbell to perform upper limb exercises (biceps curls, side curls extensions, upright row, back fly) and used Thera band to perform lower limb exercises for 10-20 minutes For Week 3 and 4; Aerobic exercise on Treadmill along with dumbbell and Thera band to perform upper limb and lower limb exercises for 30-40 minutes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Heart failure patients with ejection fraction greater than 35%

Exclusion Criteria

* Patients with unstable angina
* Patients who had severe pain in the lower limbs
* Patients with Blood pressure greater than 190/120mmHg were excluded
* Patients who had positive contraindication for cardiac rehabilitation were not admitted in this study
Minimum Eligible Age

35 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muhammad Iqbal Tariq, MSCPPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rawalpindi Institute of Cardiology

Rawalpindi, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/00880 Mahnoor Shabbir

Identifier Type: -

Identifier Source: org_study_id